NIH-funded research R01 grant

Investigating how B cells interact with T cells in a new model of multiple sclerosis

Official title: Pathogenic B cell:CD4 T cell interactions in a novel B cell-dependent EAE mouse model of multiple sclerosis

Funded at University of Iowa · NIH-10909307 · Data updated 2026-11-12

This study is looking at how certain immune cells called B cells interact with other immune cells in multiple sclerosis, using a special mouse model to help find better treatments for the disease.

More Multiple Sclerosis research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Iowa
NIH-funded
Lab location1 site (Iowa City, United States)
Project startAugust 17, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$472,369
NIH project number5R01AI177594-02
Project IDNIH-10909307 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with multiple sclerosis, particularly those who may benefit from novel B cell-targeted therapies.

Less likely to help

Patients with forms of multiple sclerosis that do not involve B cell pathology may not receive benefit from this research.

What this research studies

This research focuses on understanding the role of B cells in multiple sclerosis (MS) by using a novel animal model that emphasizes B cell-dependent mechanisms. The study aims to explore how B cells present antigens to CD4 T cells, which are crucial in the disease process. By examining these interactions, the research seeks to uncover new insights into the pathogenic mechanisms of MS, potentially leading to improved therapies. The approach involves rigorous experimentation with a specially designed mouse model that mimics the disease's characteristics.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies targeting B cell interactions in multiple sclerosis, potentially improving patient outcomes.

How similar studies have gone: Previous research has shown success in understanding B cell roles in autoimmune diseases, but this specific approach using a B cell-dependent model is relatively novel.

Where this research is happening

  • University of Iowa
    Iowa City, United States
    Active

Researchers

  • Principal investigator: Boyden, Alexander — University of Iowa
  • Study coordinator: Boyden, Alexander

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.